Canopy Growth Corp (CGC) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 166.75M CAD | Liabilities, Current |
| Cash and equivalents | 336.63M CAD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 32.55M CAD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 107.46M CAD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (CAD) | Current obligations (CAD) | Cash and equivalents (CAD) | Short-term securities (CAD) | Customer receivables (CAD) | Inventory · excluded from quick assets (CAD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | 166.75M | 336.63M | (m) | 32.55M | 107.46M | (m) |
| 2026-03-31 | (m) | 158.44M | 364.68M | (m) | 31.24M | 110.51M | (m) |
| 2025-12-31 | (m) | 98.29M | 371.32M | (m) | 29.00M | 105.56M | (m) |
| 2025-09-30 | (m) | 81.10M | 298.06M | (m) | 24.56M | 102.37M | (m) |
| 2025-06-30 | (m) | 98.67M | 126.20M | (m) | 47.97M | 93.82M | (m) |
| 2025-03-31 | (m) | 94.40M | 113.81M | (m) | 47.51M | 96.37M | (m) |
| 2024-12-31 | (m) | 97.02M | 161.91M | (m) | 44.39M | 90.75M | (m) |
| 2024-09-30 | (m) | 281.28M | 228.42M | (m) | 36.52M | 90.09M | (m) |
| 2024-06-30 | (m) | 166.60M | 192.16M | (m) | 43.51M | 84.52M | (m) |
| 2024-03-31 | (m) | 234.72M | 170.30M | (m) | 44.94M | 77.29M | (m) |
| 2023-12-31 | (m) | 221.34M | 142.75M | (m) | 50.96M | 86.92M | (m) |
| 2023-09-30 | (m) | 196.25M | 240.38M | (m) | 54.54M | 87.47M | (m) |
| 2023-06-30 | (m) | 451.16M | 533.27M | (m) | 92.50M | 142.06M | (m) |
| 2023-03-31 | (m) | 803.84M | 677.01M | (m) | 66.82M | 148.90M | (m) |
| 2022-12-31 | (m) | 678.74M | 598.13M | (m) | 85.30M | 213.94M | (m) |
| 2022-09-30 | (m) | 542.40M | 746.72M | (m) | 91.10M | 211.21M | (m) |
| 2022-06-30 | (m) | 404.41M | 769.50M | (m) | 79.11M | 205.51M | (m) |
| 2022-03-31 | (m) | 212.90M | 776.00M | (m) | 78.06M | 204.39M | (m) |
| 2021-12-31 | (m) | 239.25M | 615.15M | (m) | 82.55M | 365.75M | (m) |
| 2021-09-30 | (m) | 259.90M | 807.62M | (m) | 75.56M | 353.31M | (m) |
| 2021-06-30 | (m) | 256.13M | 559.84M | (m) | 87.58M | 411.68M | (m) |
| 2021-03-31 | (m) | 284.33M | 1.15B | (m) | 67.11M | 367.98M | (m) |
| 2020-12-31 | (m) | 348.22M | 824.96M | (m) | 74.57M | 394.02M | (m) |
| 2020-09-30 | (m) | 324.46M | 673.29M | (m) | 63.00M | 398.45M | (m) |
| 2020-06-30 | (m) | 319.68M | 975.87M | (m) | 42.22M | 389.80M | (m) |
| 2020-03-31 | (m) | 420.59M | 1.30B | (m) | 51.17M | 391.09M | (m) |
| 2019-12-31 | (m) | 96.45M | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | (m) | 411.66M | 2.48B | (m) | 61.83M | 190.07M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |